Private equity firm Veritas Capital is exploring a sale of Cotiviti Corp that could secure a valuation of over $15 billion for the healthcare analytics company, Bloomberg News reported on Tuesday, citing people with knowledge of the matter.
The firm had earlier been considering an IPO of Cotiviti, but is now weighing a sale due to a bout of volatility in the stock market, the report said.
Veritas declined to comment on the report.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
An official sales process could start as soon as January, the report added.
Cotiviti, which went public in 2016, was acquired by Veritas in 2018 in a take-private deal valued at $4.9 billion, as the PE firm looked to expand its Verscend healthcare IT business.
Source: Reuters
Can’t stop reading? Read more
Ares makes Australia private equity debut with majority stake in Redback Boots
Ares makes Australia private equity debut with majority stake in Redback Boots Ares Management has...
KKR leads $700m raise for Saviynt, valuing identity security leader at $3bn
KKR leads $700m raise for Saviynt, valuing identity security leader at $3bn KKR has led a $700m...
Blackstone joins BC Partners and Abrams in $907.5m US Salt acquisition as ContextLogic reinvents itself
Blackstone joins BC Partners and Abrams in $907.5m US Salt acquisition as ContextLogic reinvents...